The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 348:1408-1409 April 3, 2003 Number 14
NextNext

Community-Acquired Pneumonia

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Halm, E. A.
-PubMed Citation
To the Editor: Halm and Teirstein (Dec. 19 issue)1 recommend choosing antibiotics for patients with community-acquired pneumonia that cover typical and atypical pathogens but provide little discussion of which antibiotics are optimal for treating pneumonia without contributing to the pressure of emerging resistance. Fluoroquinolones, despite a high level of activity against pneumococcus and atypical organisms, are not advocated by the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group of the Centers for Disease Control and Prevention (CDC) because of their perhaps overextended spectrum of coverage (inclusive of gram-negative organisms) and concern about the emergence of resistant pneumococci.2 Studies have shown a direct . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.